LIMD1 and glioma: LIMD1-AS1 knockdown by siRNA significantly inhibited cell viability in both LN-18 and T98G glioma cells, while LIMD1-AS1 overexpression increased clonogenic ability of SF126 glioma cells (Fig. 3B, C, H–J).